Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evolution of Functional Gastrointestinal Disorders in Infants Fed With a New Infant Formula
Sponsor: United Pharmaceuticals
Summary
This study aims to assess the evolution of functional gastrointestinal disorders (FGIDs) in infants fed with a new infant formula, using the Gastrointestinal (GI) and gastroesophageal reflux (GER) (GIGER) scale through an interventional, open-label, non-comparative multicenter study.
Official title: Assessment of the Evolution of functIonal Gastrointestinal Disorders in Infants During Their Dietary Management With a New Infant Formula
Key Details
Gender
All
Age Range
Any - 4 Months
Study Type
INTERVENTIONAL
Enrollment
139
Start Date
2024-10-21
Completion Date
2026-04
Last Updated
2025-01-06
Healthy Volunteers
No
Conditions
Interventions
New infant formula
The new formula will be given to infants during the 4-month study period.
Locations (4)
Site 02
Nice, France
Site 04
Paris, France
Site 03
Toulon, France
Site 01
Vincennes, France